Roivant Sciences (ROIV) Receivables - Accured (2023 - 2026)

Roivant Sciences has reported Receivables - Accured for 4 years, with the latest figure at $19.6 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables - Accured rose 61.98% year-over-year to $19.6 million; the trailing twelve-month figure through Mar 2026 stood at $19.6 million (up 61.98% YoY), and the FY2026 full-year result was $19.6 million, up 61.98% from the prior year.
• Receivables - Accured for Q1 2026 stood at $19.6 million, up from $12.1 million in the prior quarter.
• The five-year high for Receivables - Accured was $27.4 million in Q1 2024, with the low at $4.9 million in Q1 2023.
• Historically, Receivables - Accured has averaged $17.8 million across 4 years, with a median of $19.3 million in 2023.
• Annual changes were most pronounced in 2024 — Receivables - Accured jumped 458.99% — and 2025, when it sank 55.91%.
• Roivant Sciences' Receivables - Accured stood at $18.9 million in 2023, then grew by 22.68% to $23.2 million in 2024, then slumped by 47.82% to $12.1 million in 2025, then jumped by 61.98% to $19.6 million in 2026.
• The last three Receivables - Accured figures came in at $19.6 million (Q1 2026), $12.1 million (Q1 2025), and $23.2 million (Q4 2024), per Business Quant data.